IOL Chemicals and Pharmaceuticals Limited

Profitability for 1 year: -15.25%
Dividend yield: 0%
Sector: Healthcare

Company Analysis IOL Chemicals and Pharmaceuticals Limited

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (-15.25%) is higher than the sector average (-27.53%).

Disadvantages

  • Price (74.58 β‚Ή) is higher than fair price (25.45 β‚Ή)
  • Dividends (0%) are below the sector average (0.39%).
  • Current debt level 3.35% has increased over 5 years from 0%.
  • The company's current efficiency (ROE=5.99%) is lower than the sector average (ROE=11.34%)

Similar companies

Sun Pharma Advanced Research Company Limited

Divi`s Laboratories Limited

Dr. Reddy's Laboratories Limited

Thyrocare Technologies Limited

2. Share price and performance

2.1. Share price

2.3. Market efficiency

IOL Chemicals and Pharmaceuticals Limited Healthcare Index
7 days -7.8% -15% -0.6%
90 days -10% -24.2% -1.7%
1 year -15.3% -27.5% 10.2%

IOLCP vs Sector: IOL Chemicals and Pharmaceuticals Limited has outperformed the "Healthcare" sector by 12.28% over the past year.

IOLCP vs Market: IOL Chemicals and Pharmaceuticals Limited has significantly underperformed the market by -25.47% over the past year.

Stable price: IOLCP is not significantly more volatile than the rest of the market on "Bombay Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: IOLCP with weekly volatility of -0.29% over the past year.

3. Summary of the report

3.1. General

P/E: 21.66
P/S: 1.06

3.2. Revenue

EPS 3.44
ROE 5.99%
ROA 4.24%
ROIC 0%
Ebitda margin 12.15%

5. Fundamental Analysis

5.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (74.58 β‚Ή) is higher than the fair price (25.45 β‚Ή).

Price is higher than fair: The current price (74.58 β‚Ή) is 65.9% higher than the fair price.

5.2. P/E

P/E vs Sector: The company's P/E (21.66) is lower than that of the sector as a whole (134.68).

P/E vs Market: The company's P/E (21.66) is lower than that of the market as a whole (116.07).

5.2.1 P/E Similar companies

5.3. P/BV

P/BV vs Sector: The company's P/BV (1.3) is lower than that of the sector as a whole (4.92).

P/BV vs Market: The company's P/BV (1.3) is lower than that of the market as a whole (52.77).

5.3.1 P/BV Similar companies

5.5. P/S

P/S vs Sector: The company's P/S indicator (1.06) is lower than that of the sector as a whole (15.1).

P/S vs Market: The company's P/S indicator (1.06) is lower than that of the market as a whole (74.87).

5.5.1 P/S Similar companies

5.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (6.98) is lower than that of the sector as a whole (8.19).

EV/Ebitda vs Market: The company's EV/Ebitda (6.98) is lower than that of the market as a whole (9.13).

6. Profitability

6.1. Profitability and revenue

6.2. Earnings per share - EPS

6.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -15.45% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-15.45%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.34%).

6.4. ROE

ROE vs Sector: The company's ROE (5.99%) is lower than that of the sector as a whole (11.34%).

ROE vs Market: The company's ROE (5.99%) is lower than that of the market as a whole (13.22%).

6.6. ROA

ROA vs Sector: The company's ROA (4.24%) is higher than that of the sector as a whole (3.51%).

ROA vs Market: The company's ROA (4.24%) is lower than that of the market as a whole (6.94%).

6.6. ROIC

ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (10.2%).

ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (13.97%).

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

7. Finance

7.1. Assets and debt

Debt level: (3.35%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 0% to 3.35%.

Debt Covering: The debt is covered by 78.97% from net profit.

7.2. Profit growth and share price

8. Dividends

8.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.39%.

8.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.64.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

8.3. Payout percentage

Dividend Coverage: Current payments from income (23.23%) are at an uncomfortable level.

9. Insider trades

9.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

9.2. Latest transactions

No insider transactions have been recorded yet